nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—PTGS1—Alzheimer's disease	0.618	1	CbGaD
Candesartan—CYP2C9—Donepezil—Alzheimer's disease	0.0562	1	CbGbCtD
Candesartan—Creatine phosphokinase increased—Donepezil—Alzheimer's disease	0.00403	0.016	CcSEcCtD
Candesartan—Kidney function abnormal—Memantine—Alzheimer's disease	0.00398	0.0158	CcSEcCtD
Candesartan—Kidney function abnormal—Rivastigmine—Alzheimer's disease	0.0039	0.0155	CcSEcCtD
Candesartan—Coagulopathy—Galantamine—Alzheimer's disease	0.00352	0.0139	CcSEcCtD
Candesartan—Transaminases increased—Donepezil—Alzheimer's disease	0.00349	0.0138	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Donepezil—Alzheimer's disease	0.00308	0.0122	CcSEcCtD
Candesartan—Albuminuria—Donepezil—Alzheimer's disease	0.00284	0.0113	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Rivastigmine—Alzheimer's disease	0.00274	0.0109	CcSEcCtD
Candesartan—Blood urea increased—Galantamine—Alzheimer's disease	0.00258	0.0102	CcSEcCtD
Candesartan—Albuminuria—Rivastigmine—Alzheimer's disease	0.00252	0.01	CcSEcCtD
Candesartan—Coagulopathy—Memantine—Alzheimer's disease	0.00247	0.00981	CcSEcCtD
Candesartan—Coagulopathy—Rivastigmine—Alzheimer's disease	0.00242	0.00959	CcSEcCtD
Candesartan—Gastroenteritis—Galantamine—Alzheimer's disease	0.00224	0.00889	CcSEcCtD
Candesartan—Renal impairment—Galantamine—Alzheimer's disease	0.00209	0.00828	CcSEcCtD
Candesartan—Hyperuricaemia—Memantine—Alzheimer's disease	0.00208	0.00823	CcSEcCtD
Candesartan—Cardiac failure—Galantamine—Alzheimer's disease	0.00204	0.00807	CcSEcCtD
Candesartan—Blood urea increased—Donepezil—Alzheimer's disease	0.002	0.00794	CcSEcCtD
Candesartan—Blood uric acid increased—Memantine—Alzheimer's disease	0.00196	0.00777	CcSEcCtD
Candesartan—Hyperkalaemia—Memantine—Alzheimer's disease	0.00189	0.0075	CcSEcCtD
Candesartan—Blood urea increased—Memantine—Alzheimer's disease	0.00182	0.00721	CcSEcCtD
Candesartan—Gastroenteritis—Donepezil—Alzheimer's disease	0.00174	0.00689	CcSEcCtD
Candesartan—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.0017	0.00673	CcSEcCtD
Candesartan—Bronchitis—Galantamine—Alzheimer's disease	0.00165	0.00655	CcSEcCtD
Candesartan—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.0016	0.00633	CcSEcCtD
Candesartan—Pranlukast—TNF—Alzheimer's disease	0.00159	0.319	CrCbGaD
Candesartan—Cardiac failure—Donepezil—Alzheimer's disease	0.00158	0.00625	CcSEcCtD
Candesartan—Gastroenteritis—Memantine—Alzheimer's disease	0.00158	0.00625	CcSEcCtD
Candesartan—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00155	0.00614	CcSEcCtD
Candesartan—Hyponatraemia—Donepezil—Alzheimer's disease	0.00155	0.00613	CcSEcCtD
Candesartan—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00154	0.00612	CcSEcCtD
Candesartan—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00154	0.00611	CcSEcCtD
Candesartan—Renal failure—Galantamine—Alzheimer's disease	0.0015	0.00597	CcSEcCtD
Candesartan—Renal impairment—Memantine—Alzheimer's disease	0.00147	0.00582	CcSEcCtD
Candesartan—Haematuria—Galantamine—Alzheimer's disease	0.00146	0.00579	CcSEcCtD
Candesartan—Epistaxis—Galantamine—Alzheimer's disease	0.00144	0.00572	CcSEcCtD
Candesartan—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00144	0.00572	CcSEcCtD
Candesartan—Renal impairment—Rivastigmine—Alzheimer's disease	0.00144	0.0057	CcSEcCtD
Candesartan—Cardiac failure—Memantine—Alzheimer's disease	0.00143	0.00568	CcSEcCtD
Candesartan—Hyponatraemia—Memantine—Alzheimer's disease	0.0014	0.00556	CcSEcCtD
Candesartan—Cardiac failure—Rivastigmine—Alzheimer's disease	0.0014	0.00556	CcSEcCtD
Candesartan—Haemoglobin—Galantamine—Alzheimer's disease	0.00138	0.00548	CcSEcCtD
Candesartan—Rhinitis—Galantamine—Alzheimer's disease	0.00138	0.00546	CcSEcCtD
Candesartan—Hepatitis—Galantamine—Alzheimer's disease	0.00137	0.00545	CcSEcCtD
Candesartan—Haemorrhage—Galantamine—Alzheimer's disease	0.00137	0.00545	CcSEcCtD
Candesartan—Telmisartan—PPARG—Alzheimer's disease	0.00137	0.275	CrCbGaD
Candesartan—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00137	0.00544	CcSEcCtD
Candesartan—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00136	0.00538	CcSEcCtD
Candesartan—Oedema peripheral—Galantamine—Alzheimer's disease	0.00135	0.00537	CcSEcCtD
Candesartan—Urethral disorder—Galantamine—Alzheimer's disease	0.00135	0.00534	CcSEcCtD
Candesartan—Blood creatinine increased—Memantine—Alzheimer's disease	0.00131	0.00519	CcSEcCtD
Candesartan—Sweating increased—Donepezil—Alzheimer's disease	0.0013	0.00514	CcSEcCtD
Candesartan—Angina pectoris—Donepezil—Alzheimer's disease	0.0013	0.00514	CcSEcCtD
Candesartan—Bronchitis—Donepezil—Alzheimer's disease	0.00128	0.00507	CcSEcCtD
Candesartan—Mental disorder—Galantamine—Alzheimer's disease	0.0012	0.00477	CcSEcCtD
Candesartan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.0012	0.00476	CcSEcCtD
Candesartan—Malnutrition—Galantamine—Alzheimer's disease	0.0012	0.00474	CcSEcCtD
Candesartan—Angina pectoris—Memantine—Alzheimer's disease	0.00118	0.00467	CcSEcCtD
Candesartan—Sweating increased—Memantine—Alzheimer's disease	0.00118	0.00467	CcSEcCtD
Candesartan—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00117	0.00464	CcSEcCtD
Candesartan—Renal failure—Donepezil—Alzheimer's disease	0.00117	0.00462	CcSEcCtD
Candesartan—Myocardial infarction—Donepezil—Alzheimer's disease	0.00116	0.00461	CcSEcCtD
Candesartan—Bronchitis—Memantine—Alzheimer's disease	0.00116	0.00461	CcSEcCtD
Candesartan—Back pain—Galantamine—Alzheimer's disease	0.00116	0.00459	CcSEcCtD
Candesartan—Sweating increased—Rivastigmine—Alzheimer's disease	0.00115	0.00456	CcSEcCtD
Candesartan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00115	0.00456	CcSEcCtD
Candesartan—Bronchitis—Rivastigmine—Alzheimer's disease	0.00114	0.00451	CcSEcCtD
Candesartan—Haematuria—Donepezil—Alzheimer's disease	0.00113	0.00448	CcSEcCtD
Candesartan—Neutropenia—Memantine—Alzheimer's disease	0.00113	0.00448	CcSEcCtD
Candesartan—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00112	0.00445	CcSEcCtD
Candesartan—Epistaxis—Donepezil—Alzheimer's disease	0.00112	0.00444	CcSEcCtD
Candesartan—Anaemia—Galantamine—Alzheimer's disease	0.00111	0.00438	CcSEcCtD
Candesartan—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.0011	0.00435	CcSEcCtD
Candesartan—Hyperglycaemia—Memantine—Alzheimer's disease	0.00109	0.00432	CcSEcCtD
Candesartan—Vertigo—Galantamine—Alzheimer's disease	0.00107	0.00426	CcSEcCtD
Candesartan—Haemoglobin—Donepezil—Alzheimer's disease	0.00107	0.00424	CcSEcCtD
Candesartan—Rhinitis—Donepezil—Alzheimer's disease	0.00107	0.00423	CcSEcCtD
Candesartan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00107	0.00423	CcSEcCtD
Candesartan—Haemorrhage—Donepezil—Alzheimer's disease	0.00107	0.00422	CcSEcCtD
Candesartan—Hepatitis—Donepezil—Alzheimer's disease	0.00107	0.00422	CcSEcCtD
Candesartan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00106	0.00421	CcSEcCtD
Candesartan—Renal failure—Memantine—Alzheimer's disease	0.00106	0.0042	CcSEcCtD
Candesartan—Palpitations—Galantamine—Alzheimer's disease	0.00106	0.00419	CcSEcCtD
Candesartan—Pharyngitis—Donepezil—Alzheimer's disease	0.00106	0.00419	CcSEcCtD
Candesartan—Myocardial infarction—Memantine—Alzheimer's disease	0.00106	0.00419	CcSEcCtD
Candesartan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00105	0.00417	CcSEcCtD
Candesartan—Oedema peripheral—Donepezil—Alzheimer's disease	0.00105	0.00416	CcSEcCtD
Candesartan—Urethral disorder—Donepezil—Alzheimer's disease	0.00104	0.00414	CcSEcCtD
Candesartan—Cough—Galantamine—Alzheimer's disease	0.00104	0.00414	CcSEcCtD
Candesartan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00104	0.00412	CcSEcCtD
Candesartan—Renal failure—Rivastigmine—Alzheimer's disease	0.00104	0.00411	CcSEcCtD
Candesartan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00103	0.0041	CcSEcCtD
Candesartan—Hypertension—Galantamine—Alzheimer's disease	0.00103	0.00409	CcSEcCtD
Candesartan—Haematuria—Memantine—Alzheimer's disease	0.00103	0.00407	CcSEcCtD
Candesartan—Chest pain—Galantamine—Alzheimer's disease	0.00102	0.00404	CcSEcCtD
Candesartan—Myalgia—Galantamine—Alzheimer's disease	0.00102	0.00404	CcSEcCtD
Candesartan—Arthralgia—Galantamine—Alzheimer's disease	0.00102	0.00404	CcSEcCtD
Candesartan—Epistaxis—Memantine—Alzheimer's disease	0.00102	0.00403	CcSEcCtD
Candesartan—Anxiety—Galantamine—Alzheimer's disease	0.00102	0.00402	CcSEcCtD
Candesartan—Sinusitis—Memantine—Alzheimer's disease	0.00101	0.00401	CcSEcCtD
Candesartan—Agranulocytosis—Memantine—Alzheimer's disease	0.00101	0.00399	CcSEcCtD
Candesartan—Haematuria—Rivastigmine—Alzheimer's disease	0.001	0.00398	CcSEcCtD
Candesartan—Epistaxis—Rivastigmine—Alzheimer's disease	0.000994	0.00394	CcSEcCtD
Candesartan—Sinusitis—Rivastigmine—Alzheimer's disease	0.000989	0.00392	CcSEcCtD
Candesartan—Haemoglobin—Memantine—Alzheimer's disease	0.000972	0.00385	CcSEcCtD
Candesartan—Rhinitis—Memantine—Alzheimer's disease	0.00097	0.00384	CcSEcCtD
Candesartan—Haemorrhage—Memantine—Alzheimer's disease	0.000967	0.00383	CcSEcCtD
Candesartan—Hepatitis—Memantine—Alzheimer's disease	0.000967	0.00383	CcSEcCtD
Candesartan—Pharyngitis—Memantine—Alzheimer's disease	0.00096	0.00381	CcSEcCtD
Candesartan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000956	0.00379	CcSEcCtD
Candesartan—Urinary tract disorder—Memantine—Alzheimer's disease	0.000955	0.00379	CcSEcCtD
Candesartan—Tachycardia—Galantamine—Alzheimer's disease	0.000953	0.00378	CcSEcCtD
Candesartan—Oedema peripheral—Memantine—Alzheimer's disease	0.000953	0.00378	CcSEcCtD
Candesartan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000951	0.00377	CcSEcCtD
Candesartan—Rhinitis—Rivastigmine—Alzheimer's disease	0.000948	0.00376	CcSEcCtD
Candesartan—Urethral disorder—Memantine—Alzheimer's disease	0.000948	0.00376	CcSEcCtD
Candesartan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000946	0.00375	CcSEcCtD
Candesartan—Hepatitis—Rivastigmine—Alzheimer's disease	0.000946	0.00375	CcSEcCtD
Candesartan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000944	0.00374	CcSEcCtD
Candesartan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000939	0.00372	CcSEcCtD
Candesartan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000934	0.0037	CcSEcCtD
Candesartan—Mental disorder—Donepezil—Alzheimer's disease	0.000933	0.0037	CcSEcCtD
Candesartan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000932	0.00369	CcSEcCtD
Candesartan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000927	0.00368	CcSEcCtD
Candesartan—Malnutrition—Donepezil—Alzheimer's disease	0.000927	0.00368	CcSEcCtD
Candesartan—Hypotension—Galantamine—Alzheimer's disease	0.000912	0.00362	CcSEcCtD
Candesartan—Back pain—Donepezil—Alzheimer's disease	0.000897	0.00356	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00089	0.00353	CcSEcCtD
Candesartan—Paraesthesia—Galantamine—Alzheimer's disease	0.000877	0.00348	CcSEcCtD
Candesartan—Somnolence—Galantamine—Alzheimer's disease	0.000868	0.00344	CcSEcCtD
Candesartan—Dyspepsia—Galantamine—Alzheimer's disease	0.000859	0.00341	CcSEcCtD
Candesartan—Anaemia—Donepezil—Alzheimer's disease	0.000857	0.0034	CcSEcCtD
Candesartan—Mental disorder—Memantine—Alzheimer's disease	0.000847	0.00336	CcSEcCtD
Candesartan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000843	0.00334	CcSEcCtD
Candesartan—Malnutrition—Memantine—Alzheimer's disease	0.000842	0.00334	CcSEcCtD
Candesartan—Fatigue—Galantamine—Alzheimer's disease	0.000842	0.00334	CcSEcCtD
Candesartan—Vertigo—Donepezil—Alzheimer's disease	0.000833	0.0033	CcSEcCtD
Candesartan—Mental disorder—Rivastigmine—Alzheimer's disease	0.000829	0.00329	CcSEcCtD
Candesartan—Malnutrition—Rivastigmine—Alzheimer's disease	0.000824	0.00326	CcSEcCtD
Candesartan—Irbesartan—PTGS1—Alzheimer's disease	0.000818	0.164	CrCbGaD
Candesartan—Back pain—Memantine—Alzheimer's disease	0.000814	0.00323	CcSEcCtD
Candesartan—Cough—Donepezil—Alzheimer's disease	0.000809	0.00321	CcSEcCtD
Candesartan—Hypertension—Donepezil—Alzheimer's disease	0.0008	0.00317	CcSEcCtD
Candesartan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000798	0.00317	CcSEcCtD
Candesartan—Back pain—Rivastigmine—Alzheimer's disease	0.000797	0.00316	CcSEcCtD
Candesartan—Arthralgia—Donepezil—Alzheimer's disease	0.000789	0.00313	CcSEcCtD
Candesartan—Myalgia—Donepezil—Alzheimer's disease	0.000789	0.00313	CcSEcCtD
Candesartan—Chest pain—Donepezil—Alzheimer's disease	0.000789	0.00313	CcSEcCtD
Candesartan—Anxiety—Donepezil—Alzheimer's disease	0.000787	0.00312	CcSEcCtD
Candesartan—Anaemia—Memantine—Alzheimer's disease	0.000778	0.00308	CcSEcCtD
Candesartan—Abdominal pain—Galantamine—Alzheimer's disease	0.000772	0.00306	CcSEcCtD
Candesartan—Body temperature increased—Galantamine—Alzheimer's disease	0.000772	0.00306	CcSEcCtD
Candesartan—Anaemia—Rivastigmine—Alzheimer's disease	0.000761	0.00302	CcSEcCtD
Candesartan—Vertigo—Memantine—Alzheimer's disease	0.000756	0.003	CcSEcCtD
Candesartan—Leukopenia—Memantine—Alzheimer's disease	0.000754	0.00299	CcSEcCtD
Candesartan—Palpitations—Memantine—Alzheimer's disease	0.000744	0.00295	CcSEcCtD
Candesartan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000741	0.00294	CcSEcCtD
Candesartan—Vertigo—Rivastigmine—Alzheimer's disease	0.00074	0.00293	CcSEcCtD
Candesartan—Cough—Memantine—Alzheimer's disease	0.000735	0.00291	CcSEcCtD
Candesartan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000732	0.0029	CcSEcCtD
Candesartan—Palpitations—Rivastigmine—Alzheimer's disease	0.000728	0.00289	CcSEcCtD
Candesartan—Hypertension—Memantine—Alzheimer's disease	0.000727	0.00288	CcSEcCtD
Candesartan—Cough—Rivastigmine—Alzheimer's disease	0.000719	0.00285	CcSEcCtD
Candesartan—Arthralgia—Memantine—Alzheimer's disease	0.000717	0.00284	CcSEcCtD
Candesartan—Chest pain—Memantine—Alzheimer's disease	0.000717	0.00284	CcSEcCtD
Candesartan—Myalgia—Memantine—Alzheimer's disease	0.000717	0.00284	CcSEcCtD
Candesartan—Anxiety—Memantine—Alzheimer's disease	0.000714	0.00283	CcSEcCtD
Candesartan—Hypertension—Rivastigmine—Alzheimer's disease	0.000711	0.00282	CcSEcCtD
Candesartan—Hypotension—Donepezil—Alzheimer's disease	0.000707	0.0028	CcSEcCtD
Candesartan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000701	0.00278	CcSEcCtD
Candesartan—Chest pain—Rivastigmine—Alzheimer's disease	0.000701	0.00278	CcSEcCtD
Candesartan—Myalgia—Rivastigmine—Alzheimer's disease	0.000701	0.00278	CcSEcCtD
Candesartan—Asthenia—Galantamine—Alzheimer's disease	0.000701	0.00278	CcSEcCtD
Candesartan—Anxiety—Rivastigmine—Alzheimer's disease	0.000699	0.00277	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000689	0.00273	CcSEcCtD
Candesartan—Paraesthesia—Donepezil—Alzheimer's disease	0.000679	0.00269	CcSEcCtD
Candesartan—Dyspnoea—Donepezil—Alzheimer's disease	0.000675	0.00267	CcSEcCtD
Candesartan—Somnolence—Donepezil—Alzheimer's disease	0.000673	0.00267	CcSEcCtD
Candesartan—Thrombocytopenia—Memantine—Alzheimer's disease	0.000673	0.00267	CcSEcCtD
Candesartan—Tachycardia—Memantine—Alzheimer's disease	0.000671	0.00266	CcSEcCtD
Candesartan—Diarrhoea—Galantamine—Alzheimer's disease	0.000668	0.00265	CcSEcCtD
Candesartan—Dyspepsia—Donepezil—Alzheimer's disease	0.000666	0.00264	CcSEcCtD
Candesartan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000664	0.00263	CcSEcCtD
Candesartan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000658	0.00261	CcSEcCtD
Candesartan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000656	0.0026	CcSEcCtD
Candesartan—Losartan—ACE—Alzheimer's disease	0.000655	0.131	CrCbGaD
Candesartan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000653	0.00259	CcSEcCtD
Candesartan—Fatigue—Donepezil—Alzheimer's disease	0.000652	0.00259	CcSEcCtD
Candesartan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00065	0.00258	CcSEcCtD
Candesartan—Dizziness—Galantamine—Alzheimer's disease	0.000646	0.00256	CcSEcCtD
Candesartan—Hypotension—Memantine—Alzheimer's disease	0.000642	0.00255	CcSEcCtD
Candesartan—Hypotension—Rivastigmine—Alzheimer's disease	0.000628	0.00249	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000626	0.00248	CcSEcCtD
Candesartan—Vomiting—Galantamine—Alzheimer's disease	0.000621	0.00246	CcSEcCtD
Candesartan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000619	0.00245	CcSEcCtD
Candesartan—Paraesthesia—Memantine—Alzheimer's disease	0.000617	0.00245	CcSEcCtD
Candesartan—Rash—Galantamine—Alzheimer's disease	0.000616	0.00244	CcSEcCtD
Candesartan—Dermatitis—Galantamine—Alzheimer's disease	0.000615	0.00244	CcSEcCtD
Candesartan—Dyspnoea—Memantine—Alzheimer's disease	0.000613	0.00243	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000612	0.00243	CcSEcCtD
Candesartan—Headache—Galantamine—Alzheimer's disease	0.000612	0.00242	CcSEcCtD
Candesartan—Somnolence—Memantine—Alzheimer's disease	0.000611	0.00242	CcSEcCtD
Candesartan—Dyspepsia—Memantine—Alzheimer's disease	0.000605	0.0024	CcSEcCtD
Candesartan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000604	0.00239	CcSEcCtD
Candesartan—Urticaria—Donepezil—Alzheimer's disease	0.000601	0.00238	CcSEcCtD
Candesartan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000599	0.00238	CcSEcCtD
Candesartan—Abdominal pain—Donepezil—Alzheimer's disease	0.000598	0.00237	CcSEcCtD
Candesartan—Body temperature increased—Donepezil—Alzheimer's disease	0.000598	0.00237	CcSEcCtD
Candesartan—Somnolence—Rivastigmine—Alzheimer's disease	0.000598	0.00237	CcSEcCtD
Candesartan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000593	0.00235	CcSEcCtD
Candesartan—Fatigue—Memantine—Alzheimer's disease	0.000592	0.00235	CcSEcCtD
Candesartan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000592	0.00235	CcSEcCtD
Candesartan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00058	0.0023	CcSEcCtD
Candesartan—Nausea—Galantamine—Alzheimer's disease	0.00058	0.0023	CcSEcCtD
Candesartan—Fatigue—Rivastigmine—Alzheimer's disease	0.000579	0.0023	CcSEcCtD
Candesartan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000562	0.00223	CcSEcCtD
Candesartan—Irbesartan—CYP2D6—Alzheimer's disease	0.000557	0.111	CrCbGaD
Candesartan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00055	0.00218	CcSEcCtD
Candesartan—Urticaria—Memantine—Alzheimer's disease	0.000546	0.00216	CcSEcCtD
Candesartan—Abdominal pain—Memantine—Alzheimer's disease	0.000543	0.00215	CcSEcCtD
Candesartan—Body temperature increased—Memantine—Alzheimer's disease	0.000543	0.00215	CcSEcCtD
Candesartan—Asthenia—Donepezil—Alzheimer's disease	0.000543	0.00215	CcSEcCtD
Candesartan—Pruritus—Donepezil—Alzheimer's disease	0.000535	0.00212	CcSEcCtD
Candesartan—Urticaria—Rivastigmine—Alzheimer's disease	0.000534	0.00212	CcSEcCtD
Candesartan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000531	0.00211	CcSEcCtD
Candesartan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000531	0.00211	CcSEcCtD
Candesartan—Diarrhoea—Donepezil—Alzheimer's disease	0.000518	0.00205	CcSEcCtD
Candesartan—Dizziness—Donepezil—Alzheimer's disease	0.0005	0.00198	CcSEcCtD
Candesartan—Asthenia—Memantine—Alzheimer's disease	0.000493	0.00195	CcSEcCtD
Candesartan—Pruritus—Memantine—Alzheimer's disease	0.000486	0.00193	CcSEcCtD
Candesartan—Asthenia—Rivastigmine—Alzheimer's disease	0.000482	0.00191	CcSEcCtD
Candesartan—Vomiting—Donepezil—Alzheimer's disease	0.000481	0.00191	CcSEcCtD
Candesartan—Rash—Donepezil—Alzheimer's disease	0.000477	0.00189	CcSEcCtD
Candesartan—Dermatitis—Donepezil—Alzheimer's disease	0.000477	0.00189	CcSEcCtD
Candesartan—Pruritus—Rivastigmine—Alzheimer's disease	0.000476	0.00189	CcSEcCtD
Candesartan—Headache—Donepezil—Alzheimer's disease	0.000474	0.00188	CcSEcCtD
Candesartan—Diarrhoea—Memantine—Alzheimer's disease	0.00047	0.00186	CcSEcCtD
Candesartan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00046	0.00182	CcSEcCtD
Candesartan—Dizziness—Memantine—Alzheimer's disease	0.000454	0.0018	CcSEcCtD
Candesartan—Nausea—Donepezil—Alzheimer's disease	0.000449	0.00178	CcSEcCtD
Candesartan—Dizziness—Rivastigmine—Alzheimer's disease	0.000444	0.00176	CcSEcCtD
Candesartan—Vomiting—Memantine—Alzheimer's disease	0.000437	0.00173	CcSEcCtD
Candesartan—Rash—Memantine—Alzheimer's disease	0.000433	0.00172	CcSEcCtD
Candesartan—Dermatitis—Memantine—Alzheimer's disease	0.000433	0.00172	CcSEcCtD
Candesartan—Headache—Memantine—Alzheimer's disease	0.00043	0.00171	CcSEcCtD
Candesartan—Vomiting—Rivastigmine—Alzheimer's disease	0.000427	0.00169	CcSEcCtD
Candesartan—Rash—Rivastigmine—Alzheimer's disease	0.000424	0.00168	CcSEcCtD
Candesartan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000423	0.00168	CcSEcCtD
Candesartan—Headache—Rivastigmine—Alzheimer's disease	0.000421	0.00167	CcSEcCtD
Candesartan—Nausea—Memantine—Alzheimer's disease	0.000408	0.00162	CcSEcCtD
Candesartan—Nausea—Rivastigmine—Alzheimer's disease	0.000399	0.00158	CcSEcCtD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.18e-05	0.00076	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	5.17e-05	0.000758	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ACHE—Alzheimer's disease	5.14e-05	0.000754	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—INPP5D—Alzheimer's disease	5.08e-05	0.000746	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DHCR24—Alzheimer's disease	5.06e-05	0.000743	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	5.02e-05	0.000737	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	4.98e-05	0.000731	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA4—Alzheimer's disease	4.94e-05	0.000725	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.88e-05	0.000716	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.83e-05	0.000708	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS1—Alzheimer's disease	4.82e-05	0.000707	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ENO1—Alzheimer's disease	4.82e-05	0.000707	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	4.78e-05	0.000701	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	4.76e-05	0.000698	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	4.73e-05	0.000694	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	4.73e-05	0.000694	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP2D6—Alzheimer's disease	4.72e-05	0.000693	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	4.64e-05	0.000681	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	4.61e-05	0.000676	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	4.59e-05	0.000673	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	4.53e-05	0.000664	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—BCHE—Alzheimer's disease	4.48e-05	0.000657	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.46e-05	0.000655	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	4.43e-05	0.00065	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.41e-05	0.000647	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	4.4e-05	0.000646	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.38e-05	0.000643	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	4.35e-05	0.000638	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	4.33e-05	0.000635	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	4.3e-05	0.000632	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA4—Alzheimer's disease	4.3e-05	0.000631	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	4.28e-05	0.000628	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	4.27e-05	0.000626	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PLCB1—Alzheimer's disease	4.23e-05	0.00062	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLD3—Alzheimer's disease	4.2e-05	0.000616	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.2e-05	0.000616	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.15e-05	0.000609	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	4.15e-05	0.000609	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	4.15e-05	0.000609	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SST—Alzheimer's disease	4.15e-05	0.000609	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	4.13e-05	0.000606	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	4.11e-05	0.000604	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCA1—Alzheimer's disease	4.1e-05	0.000601	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.06e-05	0.000596	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	4.05e-05	0.000594	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APP—Alzheimer's disease	4.04e-05	0.000593	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	4.03e-05	0.000591	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA4—Alzheimer's disease	4.02e-05	0.00059	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	4e-05	0.000587	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.94e-05	0.000579	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.93e-05	0.000577	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.93e-05	0.000577	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	3.88e-05	0.00057	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	3.88e-05	0.000569	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	3.83e-05	0.000563	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	3.82e-05	0.00056	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.79e-05	0.000557	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	3.78e-05	0.000555	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ND1—Alzheimer's disease	3.74e-05	0.000549	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TPI1—Alzheimer's disease	3.73e-05	0.000548	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CHAT—Alzheimer's disease	3.73e-05	0.000548	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	3.7e-05	0.000543	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLD3—Alzheimer's disease	3.66e-05	0.000537	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.66e-05	0.000537	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	3.58e-05	0.000526	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MAOB—Alzheimer's disease	3.58e-05	0.000525	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	3.56e-05	0.000522	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	3.54e-05	0.000519	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARGC1A—Alzheimer's disease	3.53e-05	0.000518	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—HMOX1—Alzheimer's disease	3.51e-05	0.000516	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.51e-05	0.000515	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	3.48e-05	0.00051	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	3.46e-05	0.000508	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GAPDH—Alzheimer's disease	3.45e-05	0.000506	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLD3—Alzheimer's disease	3.42e-05	0.000502	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.42e-05	0.000502	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.41e-05	0.0005	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.4e-05	0.000499	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.38e-05	0.000496	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	3.38e-05	0.000495	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.38e-05	0.000495	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.35e-05	0.000491	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—A2M—Alzheimer's disease	3.33e-05	0.000488	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.31e-05	0.000486	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	3.29e-05	0.000483	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.28e-05	0.000481	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ND1—Alzheimer's disease	3.26e-05	0.000479	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—LPL—Alzheimer's disease	3.21e-05	0.000472	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.2e-05	0.00047	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.15e-05	0.000463	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.15e-05	0.000462	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	3.13e-05	0.000459	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.05e-05	0.000447	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	3.03e-05	0.000444	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.98e-05	0.000437	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.97e-05	0.000435	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.92e-05	0.000429	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	2.9e-05	0.000426	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ACHE—Alzheimer's disease	2.9e-05	0.000425	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—Alzheimer's disease	2.89e-05	0.000425	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.88e-05	0.000423	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	2.88e-05	0.000422	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INPP5D—Alzheimer's disease	2.86e-05	0.00042	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	2.82e-05	0.000414	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	2.75e-05	0.000403	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.72e-05	0.0004	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ENO1—Alzheimer's disease	2.71e-05	0.000398	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CALM1—Alzheimer's disease	2.7e-05	0.000397	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—Alzheimer's disease	2.69e-05	0.000395	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.68e-05	0.000394	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	2.67e-05	0.000392	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAV1—Alzheimer's disease	2.67e-05	0.000392	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	2.66e-05	0.00039	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.63e-05	0.000385	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	2.62e-05	0.000384	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BCHE—Alzheimer's disease	2.52e-05	0.00037	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.48e-05	0.000364	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	2.44e-05	0.000358	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	2.43e-05	0.000357	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	2.43e-05	0.000357	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TPI1—Alzheimer's disease	2.41e-05	0.000354	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CHAT—Alzheimer's disease	2.41e-05	0.000354	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	2.41e-05	0.000354	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PLCB1—Alzheimer's disease	2.38e-05	0.000349	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.38e-05	0.000349	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.35e-05	0.000344	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—Alzheimer's disease	2.35e-05	0.000344	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.33e-05	0.000343	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	2.32e-05	0.000341	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MAOB—Alzheimer's disease	2.31e-05	0.000339	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCA1—Alzheimer's disease	2.31e-05	0.000339	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—INS—Alzheimer's disease	2.3e-05	0.000338	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—F2—Alzheimer's disease	2.29e-05	0.000337	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.27e-05	0.000334	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.24e-05	0.000329	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	2.23e-05	0.000327	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.2e-05	0.000323	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.18e-05	0.00032	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—A2M—Alzheimer's disease	2.15e-05	0.000315	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.14e-05	0.000314	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.12e-05	0.000312	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	2.11e-05	0.000309	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.1e-05	0.000308	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.1e-05	0.000308	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	2.09e-05	0.000307	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—INS—Alzheimer's disease	2.08e-05	0.000305	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	2.04e-05	0.0003	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—Alzheimer's disease	2.02e-05	0.000296	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.01e-05	0.000296	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	2.01e-05	0.000295	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.99e-05	0.000292	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.98e-05	0.00029	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.96e-05	0.000288	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.96e-05	0.000288	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.94e-05	0.000285	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.92e-05	0.000281	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.88e-05	0.000276	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—A2M—Alzheimer's disease	1.87e-05	0.000275	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.87e-05	0.000275	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.87e-05	0.000274	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.85e-05	0.000271	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—Alzheimer's disease	1.85e-05	0.000271	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	1.82e-05	0.000267	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.81e-05	0.000266	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—Alzheimer's disease	1.81e-05	0.000266	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.79e-05	0.000263	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.77e-05	0.00026	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.75e-05	0.000257	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.75e-05	0.000257	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.75e-05	0.000257	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.72e-05	0.000252	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.63e-05	0.000239	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.63e-05	0.000239	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.63e-05	0.000239	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.61e-05	0.000236	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.58e-05	0.000232	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.56e-05	0.000229	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.56e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	1.55e-05	0.000227	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.54e-05	0.000226	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	1.54e-05	0.000226	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.53e-05	0.000224	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.53e-05	0.000224	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.52e-05	0.000223	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.52e-05	0.000223	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—Alzheimer's disease	1.52e-05	0.000223	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.51e-05	0.000221	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.5e-05	0.000221	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.5e-05	0.000221	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.5e-05	0.00022	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.49e-05	0.000219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.43e-05	0.000209	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.43e-05	0.000209	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	1.42e-05	0.000209	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.42e-05	0.000208	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	1.42e-05	0.000208	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.4e-05	0.000205	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.34e-05	0.000197	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.33e-05	0.000195	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—Alzheimer's disease	1.32e-05	0.000194	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.31e-05	0.000193	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.3e-05	0.000191	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INS—Alzheimer's disease	1.3e-05	0.00019	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.28e-05	0.000188	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.28e-05	0.000188	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.25e-05	0.000184	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.23e-05	0.00018	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.000178	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	1.21e-05	0.000177	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.17e-05	0.000172	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—Alzheimer's disease	1.14e-05	0.000167	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.12e-05	0.000164	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.11e-05	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	1.05e-05	0.000154	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.05e-05	0.000153	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.04e-05	0.000153	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—Alzheimer's disease	1.04e-05	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—Alzheimer's disease	1.02e-05	0.000149	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	9.92e-06	0.000146	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CALM1—Alzheimer's disease	9.83e-06	0.000144	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—Alzheimer's disease	9.8e-06	0.000144	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAV1—Alzheimer's disease	9.71e-06	0.000143	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—Alzheimer's disease	9.52e-06	0.00014	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—Alzheimer's disease	9.28e-06	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—Alzheimer's disease	9.17e-06	0.000135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	9.08e-06	0.000133	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CALM1—Alzheimer's disease	8.57e-06	0.000126	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	8.57e-06	0.000126	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—Alzheimer's disease	8.54e-06	0.000125	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—Alzheimer's disease	8.54e-06	0.000125	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAV1—Alzheimer's disease	8.46e-06	0.000124	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	8.38e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INS—Alzheimer's disease	8.37e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CALM1—Alzheimer's disease	8e-06	0.000117	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—Alzheimer's disease	7.98e-06	0.000117	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAV1—Alzheimer's disease	7.9e-06	0.000116	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—Alzheimer's disease	7.44e-06	0.000109	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—Alzheimer's disease	7.34e-06	0.000108	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INS—Alzheimer's disease	7.29e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—Alzheimer's disease	6.95e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INS—Alzheimer's disease	6.81e-06	0.0001	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	6.72e-06	9.86e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—Alzheimer's disease	6.4e-06	9.39e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—Alzheimer's disease	5.98e-06	8.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—Alzheimer's disease	5.85e-06	8.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	5.47e-06	8.02e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—Alzheimer's disease	5.23e-06	7.67e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—Alzheimer's disease	3.38e-06	4.95e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.94e-06	4.32e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—Alzheimer's disease	2.75e-06	4.03e-05	CbGpPWpGaD
